Deina H. Walsh
Chief Financial OfficerMs. Deina H. Walsh, C.P.A., has been the Chief Financial Officer of Bone Biologics Corporation since November 2014 and served as its Treasure and Secretary and also served as its Principal Accounting Officer since November 4, 2014 until May 7, 2016. Ms. Walsh has been an Owner/Founder of DHW CPA, PLLC, a Public Companies Accounting Oversight Board (PCAOB) registered firm since 2014. She spent many years at a public accounting firm, where she was a Partner and was actively responsible for leading audit engagements of publicly held entities in accordance with PCAOB standards and compliance with SEC regulations, including internal control requirements under section 404 of the Sarbanes-Oxley Act. Ms. Walsh had a global client base including entities throughout the United States, Canada and China. Her experience includes work with start-up companies and well-established operating entities. She has assisted many entities seeking debt and equity capital. She is a certified public accountant. Her areas of specialty include mergers, acquisitions, reverse mergers, consolidations, complex equity structures, foreign currency translations and revenue recognition complexities. Ms. Walsh has an Associates of Science Degree in Business Administration from Monroe Community College and a Bachelor of Science Degree in Accounting from the State University of New York at Brockport.
Positions
- Company NameBone Biologics CorporationStock CodeBBLGPositionChief Financial Officer
